Tacrolimus model
Indication: Kidney transplant immunosuppression
Interactive tacrolimus population PK simulator with CYP3A genotype-guided dosing (PM/IM/EM) for kidney transplant recipients. Based on Woillard et al. 2017.
Drug Overview
Clinical Context
- Molecular Target
- Calcineurin
- Drug Class
- Calcineurin inhibitor (Immunosuppressant)
- Therapeutic Area
- Transplantation / Nephrology
- Indication
- Kidney transplant immunosuppression
- Route of Administration
- Oral
Model Information
- Model Type
- PopPK
- Reference
- Woillard et al. (2017) Front Pharmacol
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
Pharmacokinetic Parameters
PK Parameters
| Parameter | Value |
|---|---|
| F | 0.16 |
| Ka | 0.23 h⁻¹ |
| CL F | 0.99 L/h/kg (PM genotype) |
| t half | ~12 h |
Additional Parameters
| Parameter | Value |
|---|---|
| V F | 3.3 L/kg |
Parameters sourced from published population pharmacokinetic models. Values represent typical population estimates; individual patient parameters may vary.
About This Simulator
This interactive pharmacokinetic simulator for Tacrolimus model allows you to explore concentration-time profiles under different dosing scenarios. The underlying PopPK model characterizes the pharmacokinetics of this calcineurin inhibitor (immunosuppressant) following oral administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Tacrolimus model PK simulator?
This is a free, interactive pharmacokinetic simulator for Tacrolimus model used in Kidney transplant immunosuppression. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Tacrolimus model belong to?
Tacrolimus model is classified as a Calcineurin inhibitor (Immunosuppressant) that targets Calcineurin. It is used in the Transplantation / Nephrology therapeutic area.
What route of administration does this model simulate?
This simulator models Oral administration of Tacrolimus model. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a PopPK model. Population PK models account for interindividual variability and covariate effects on drug exposure.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
What is the half-life of Tacrolimus model?
Based on the published model parameters, the elimination half-life of Tacrolimus model is approximately ~12 h. Note that half-life can vary based on patient-specific factors such as body weight, organ function, and genetic polymorphisms.
What is the clearance of Tacrolimus model?
The clearance (CL) of Tacrolimus model is approximately 0.99 L/h/kg (PM genotype). Clearance represents the volume of plasma from which drug is completely removed per unit time and is a key determinant of drug exposure and steady-state concentrations.
Ready to Simulate?
Launch the Tacrolimus model simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community